Heat Biologics Reports Third-quarter 2017 Results and Corporate Update

Nov 13, 2017

Heat Biologics Presents Follow-up Data on its ComPACT™ T-cell Stimulating Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 11, 2017

Heat Biologics to Present Data on its ComPACT Technology, at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 6, 2017

Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives Second Tranche of its $15.2 Million CPRIT Grant Award

Oct 30, 2017

Heat Biologics Rights Offering Materials Available for Shareholders of Record

Oct 27, 2017

Heat Biologics and its Pelican Therapeutics Subsidiary Appoint Two New Members to their Scientific Advisory Boards

Oct 23, 2017

Heat Biologics Announces Pricing for Rights Offering to Stockholders and Participating Warrant Holders

Oct 16, 2017

UPDATE: Heat Biologics to Present at the Upcoming BIO Investor Forum in San Francisco

Oct 12, 2017

Heat Biologics Announces Expected Calendar for Rights Offering

Sep 28, 2017

Pelican Therapeutics Announces Manufacturing Agreement with KBI Biopharma to Advance Cancer-targeting Immunotherapies

Sep 27, 2017